- Home
- VCEL vs MLCO Comparison
VCEL vs MLCO Comparison
Compare VCEL & MLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VCEL | MLCO |
|---|---|---|
| Founded | 1989 | 2003 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.2B |
| IPO Year | 1996 | 2006 |
Fundamental Metrics
Financial Performance| Metric | VCEL | MLCO |
|---|---|---|
| Price | $44.74 | $5.48 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 5 |
| Target Price | ★ $57.75 | $10.10 |
| AVG Volume (30 Days) | 463.2K | ★ 1.9M |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 60.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $276,259,000.00 | N/A |
| Revenue This Year | $19.40 | $5.42 |
| Revenue Next Year | $18.24 | $4.37 |
| P/E Ratio | ★ N/A | $12.16 |
| Revenue Growth | ★ 16.45 | N/A |
| 52 Week Low | $28.95 | $5.07 |
| 52 Week High | $49.32 | $10.15 |
Technical Indicators
Market Signals| Indicator | VCEL | MLCO |
|---|---|---|
| Relative Strength Index (RSI) | 48.74 | 48.92 |
| Support Level | $44.26 | $5.40 |
| Resistance Level | $49.04 | $5.75 |
| Average True Range (ATR) | 1.47 | 0.15 |
| MACD | -0.46 | -0.01 |
| Stochastic Oscillator | 25.77 | 26.60 |
Price Performance
Historical ComparisonAbout VCEL Vericel Corporation
Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
About MLCO Melco Resorts & Entertainment Limited
Melco Resorts & Entertainment is one of only six licensed casino operators in Macao. It operates Altira, a complex focused on premium customers; City of Dreams, an integrated resort in Cotai serving both mass-market and premium patrons; and Mocha Clubs' electronic gaming machines. The company also has a majority interest in Studio City, which opened in 2015. Outside Macao, Melco owns City of Dreams Manila in the Philippines and City of Dreams Mediterranean in Cyprus. The business mix in terms of adjusted EBITDA was about 84% from Macao, with the rest from overseas as of 2025.